Brandon D. Brown, M.D.
Department of Pediatrics, Division of Pediatrics
Present Title & Affiliation
Primary Appointment
Assistant Professor, Pediatrics Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Assistant Professor, Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2015 | American University of the Caribbean School of Medicine, Cupecoy, SX, Doctor of Medicine |
| 2010 | University of Texas at Austin, Austin, Texas, US, Biology, Bachelor of Science |
Postgraduate Training
| 2019-2022 | Clinical Fellowship, Pediatric Hematology & Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2016-2019 | Clinical Residency, Pediatrics, Saint Peter’s University Hospital, New Brunswick, New Jersey |
Licenses & Certifications
| 2019 | American Board of Pediatrics, General Pediatrics |
Experience & Service
Administrative Appointments/Responsibilities
Division Representative, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2023 - Present
Intramural Institutional Committee Activities
Search Committee Interviewer, CAC/MHCH APP Candidate Search Committee, The University of Texas MD Anderson Cancer Center, 2023
Search Committee Interviewer, Hospitalist Candidate Search Committee, The University of Texas MD Anderson Cancer Center, 2022 - 2023
Content expert committee member, Scientific Review Committee # 4 (SRC 4) MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2022 - Present
Member, Pediatric Fellowship Program Evaluation Committee, The University of Texas MD Anderson Cancer Center, 2021 - Present
Trainee Leader, CCH-Diversity, Equity, & Inclusion Council, The University of Texas MD Anderson Cancer Center, 2021 - 2022
Member, Committee for Diversity & Equality, The University of Texas MD Anderson Cancer Center, 2020 - 2022
Participant, Pediatric Stem Cell Transplant Clinical Trials Team, The University of Texas MD Anderson Cancer Center, 2020 - 2022
Member, House Staff Senate, The University of Texas MD Anderson Cancer Center, 2019 - 2022
Member, Pediatric Residency Program Evaluation Committee, Saint Peter's University Hospital, 2016 - 2018
Member, Institutional Patient Safety Committee, Saint Peter's University Hospital, 2016 - 2018
Member, Institutional Performance Improvement Committee, Saint Peter's University Hospital, 2016 - 2018
Program Representative, Institutional Resident Council, Saint Peter's University Hospital, 2016 - 2017
Honors & Awards
| 2022 | A. Somberg Endowed Fellow in Stem Cell Transplant or Therapy Award, MD Anderson Cancer Center |
| 2021 | ASH Abstract Achievement Award, American Society of Hematology |
| 2021 | Trainee Leadership Program, Certificate, MD Anderson Cancer Center |
| 2020 - 2021 | Excellence in Non-Neural Solid Tumor, Award, MD Anderson Cancer Center |
| 2020 | Excellence in Pediatric Hematology Award, MD Anderson Cancer Center |
| 2019 | Resident Educator of the Year, Award, Saint Peter’s University Hospital |
| 2019 | Resident Extraordinaire of the Year, Award, Saint Peter’s University Hospital |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2021. Haploidentical HCT in Beta Thalassemia Interdisciplinary M&M. Conference. Haploidentical HCT in Beta Thalassemia Interdisciplinary M&M. Houston, TX, US.
- 2021. Adverse Effects of Tyrosine Kinase Inhibitors and other Targeted Therapy in Sarcoma. Conference. Adverse Effects of Tyrosine Kinase Inhibitors and other Targeted Therapy in Sarcoma. Houston, TX, US.
- 2020. High Risk Leukemia: Infections & Supportive Care. Conference. High Risk Leukemia: Infections & Supportive Care. Houston, TX, US.
- 2020. Post-Transplant Lymphoproliferative Disorder. Conference. Post-Transplant Lymphoproliferative Disorder. Houston, TX, US.
- 2018. “A Novel ELA-2 Mutation in Inherited Neutropenia: A Case Series,”. Conference. “A Novel ELA-2 Mutation in Inherited Neutropenia: A Case Series,”. New Brunswick, NJ, US.
- 2017. “Isolated Lymph Node Metastases in Medulloblastoma: A Case Report,”. Conference. “Isolated Lymph Node Metastases in Medulloblastoma: A Case Report,”. New Brunswick, NJ, US.
Regional Presentations
- 2015. “Combined Subcutaneous, Intra-abdominal and Thoracic Splenosis: A Noninvasive Diagnosis in the Age of Nuclear Medicine,”. Conference. “Combined Subcutaneous, Intra-abdominal and Thoracic Splenosis: A Noninvasive Diagnosis in the Age of Nuclear Medicine,”. Syracuse, NY, US.
National Presentations
- 2021. “Proteomic Signature Prognostic for Response to Venetoclax in Adults with Acute Myeloid Leukemia,”. Conference. “Proteomic Signature Prognostic for Response to Venetoclax in Adults with Acute Myeloid Leukemia,”. Atlanta, GA, US.
- 2021. “Neurologic Complications, Differential Diagnosis and Imaging Findings after Cellular Therapy,”. Conference. “Neurologic Complications, Differential Diagnosis and Imaging Findings after Cellular Therapy,”. Houston, TX, US.
- 2021. Contemporary Critical Care Complications of SCT/Cellular Therapies. Conference. Contemporary Critical Care Complications of SCT/Cellular Therapies, US.
- 2020. “Immune Effector Cell Associated Neurotoxicity (ICANS) Among Pediatric & AYA Patients,”. Conference. “Immune Effector Cell Associated Neurotoxicity (ICANS) Among Pediatric & AYA Patients,”. Virtual Conference, US.
- 2020. “Pre-COVID19 Food Insecurity Prevalence and Risk Factors in Caregivers of Pediatric Cancer Patients at a Children’s Cancer Hospital,”. Conference. “Pre-COVID19 Food Insecurity Prevalence and Risk Factors in Caregivers of Pediatric Cancer Patients at a Children’s Cancer Hospital,”. Virtual Conference, US.
- 2020. “Food Insecurity: The MD Anderson Children’s Cancer Hospital’s Experience with A Global Health Crisis,”. Conference. “Food Insecurity: The MD Anderson Children’s Cancer Hospital’s Experience with A Global Health Crisis,”. Virtual Conference, US.
- 2020. “Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) Among Pediatric & AYA Patients: MD Anderson Cancer Center Experience,”. Conference. “Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) Among Pediatric & AYA Patients: MD Anderson Cancer Center Experience,”. Orlando, FL, US.
- 2018. Section on Pediatric Trainees. Conference. Section on Pediatric Trainees. Orlando, FL, US.
- 2017. Section on Pediatric Trainees. Conference. Section on Pediatric Trainees. Chicago, IL, US.
International Presentations
- 2022. "Pre-transplant Immunosuppression and Related Haploidentical Hematopoietic Cell Transplantation in Pediatric Patients with Hemoglobinopathies: Successful Engraftment and No Severe GVHD,”. Conference. "Pre-transplant Immunosuppression and Related Haploidentical Hematopoietic Cell Transplantation in Pediatric Patients with Hemoglobinopathies: Successful Engraftment and No Severe GVHD,”. Virtual Conference.
- 2021. “ECMO in Pediatric HTC/IEC: International Consensus Recommendations,”. Conference. “ECMO in Pediatric HTC/IEC: International Consensus Recommendations,”. New York, US.
Selected Publications
Peer-Reviewed Articles
- Chakraborty, S, Morganti, C, Zaldana, K, Rivera Pena, B, Zhang, H, Verma, D, Gitego, N, Ma, F, Alluri, S, Pradhan, K, Gordon-Mitchell, S, Mantzaris, I, Goldfinger, M, Feldman, E, Gritsman, K, Shi, Y, Hubner, SE, Qiu, Y, Brown, BD, Khasawneh, A, Skwarska, A, de Camargo Magalhães, ES, Verma, AK, Konopleva, M, Tabe, Y, Gavathiotis, E, Colla, S, Gollob, JA, Dey, J, Kornblau, SM, Koralov, SB, Ito, K, Shastri, A. A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemia. Leukemia 40(4):717-729, 2026. e-Pub 2026. PMID: 41703028.
- Balis, FM, Green, DM, Armstrong, AE, Aye, JM, Benedetti, DJ, Brown, BD, Brown, E, Cook, S, Desai, AV, Dhillon, J, Fair, DB, Geynisman, DM, Hiniker, SM, Horst, K, Jasty-Rao, R, Just, M, Kieran, K, Lin, C, MacEwan, I, Martinez-Agosto, JA, Mullen, EA, Murphy, E, Pinto, N, Ranalli, M, Rhee, DS, Rokitka, D, Walz, AL, Wickiser, JE, Yoon, J, Zapala, M, Montgomery, S, Sliker, B. Wilms Tumor, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. JNCCN Journal of the National Comprehensive Cancer Network 23(8):319-342, 2025. e-Pub 2025. PMID: 40763792.
- Narayanan N, Marvin-Peek J, Abouelnaaj MK, Majid D, Wang B, Brown BD, Qiu Y, Kornblau SM, Abbas HA. Reverse Phase Proteomic Array Profiling of Asparagine Synthetase Expression in Newly Diagnosed Acute Myeloid Leukemia. J Proteome Res 23(7):2495-2504, 2024. e-Pub 2024. PMID: 38829961.
- de Camargo Magalhães, ES, Hubner, SE, Brown, BD, Qiu, Y, Kornblau, SM. Proteomics for optimizing therapy in acute myeloid leukemia. Leukemia 38(5):1046-1056, 2024. e-Pub 2024. PMID: 38531950.
- Hoff, FW, Qiu, Y, Brown, BD, Gerbing, RB, Leonti, AR, Ries, RE, Gamis, A, Aplenc, R, Kolb, EA, Alonzo, TA, Meshinchi, S, Jenkins, GN, Horton, T, Kornblau, SM. Valosin-containing protein (VCP/p97) is prognostically unfavorable in pediatric AML, and negatively correlates with unfolded protein response proteins IRE1 and GRP78. Proteomics - Clinical Applications 17(6), 2023. e-Pub 2023. PMID: 37287368.
- Hoff, FW, Griffen, TL, Brown, BD, Horton, T, Burger, JA, Wierda, WG, Hubner, SE, Qiu, Y, Kornblau, SM. Reverse Phase Protein Array Profiling Identifies Recurrent Protein Expression Patterns of DNA Damage-Related Proteins across Acute and Chronic Leukemia. International journal of molecular sciences 24(6), 2023. e-Pub 2023. PMID: 36982537.
- Hubner, SE, de Camargo Magalhães, ES, Hoff, FW, Brown, BD, Qiu, Y, Horton, T, Kornblau, SM. DNA Damage Response−Related Proteins Are Prognostic for Outcome in Both Adult and Pediatric Acute Myelogenous Leukemia Patients. International journal of molecular sciences 24(6), 2023. e-Pub 2023. PMID: 36982970.
- Brown, BD, Tambaro, FP, Kohorst, MA, Chi, TL, Mahadeo, KM, Tewari, P, Petropoulos, D, Slopis, JM, Sadighi, ZS, Khazal, SJ. Immune Effector Cell Associated Neurotoxicity (ICANS) in Pediatric and Young Adult Patients Following Chimeric Antigen Receptor (CAR) T-Cell Therapy. Frontiers in Oncology 11, 2021. e-Pub 2021. PMID: 33763368.
- Ahmad AH, Brown BD, Andersen CR, Mahadeo KM, Petropolous D, Cortes JA, Razvi S, Gardner MK, Ewing LJ, Mejia RE. Retrospective Review of Flexible Bronchoscopy in Pediatric Cancer Patients. Front Oncol 11:770523, 2021. e-Pub 2021. PMID: 34970488.
- Tan AY, Brown BD, Scholl B, Mohanty D, Priebe NJ. Orientation selectivity of synaptic input to neurons in mouse and cat primary visual cortex. J Neurosci 31(34):12339-50, 2011. e-Pub 2011. PMID: 21865476.
Invited Articles
- Brown BD, MD, Brill S, MD. Health Care Disparities in Sexual and Gender Minority Youth(ISSN 2375-477X):12-16, 2018. e-Pub 2018.
Review Articles
- Di Nardo, M, Ahmad, AH, Merli, P, Zinter, MS, Lehman, L, Rowan, CM, Steiner, ME, Hingorani, S, Angelo, J, Abdel-Azim, H, Khazal, SJ, Shoberu, B, McArthur, J, Bajwa, R, Ghafoor, S, Shah, SH, Sandhu, H, Moody, K, Brown, BD, Mireles, ME, Steppan, D, Olson, T, Raman, L, Bridges, B, Duncan, C, Choi, SW, Swinford, R, Paden, M, Fortenberry, JD, Peek, G, Tissieres, P, De Luca, D, Locatelli, F, Corbacioglu, S, Kneyber, M, Franceschini, A, Nadel, S, Kumpf, M, Loreti, A, Wösten-Van Asperen, R, Gawronski, O, Brierley, J, MacLaren, G, Mahadeo, KM. Extracorporeal membrane oxygenation in children receiving haematopoietic cell transplantation and immune effector cell therapy. The Lancet Child and Adolescent Health 6(2):116-128, 2022. e-Pub 2022. PMID: 34895512.
Book Chapters
- Ragoonanan, D, Brown, BD, Mahadeo, KM. Miscellaneous Complications of Hematopoietic Cellular Transplantation. In: Manual of Stem Cell Transplantation and Cellular Therapies for Hematologic Malignancies, 481-507, 2023.
Letters to the Editor
- Sheikh, IN, Alqahtani, S, Okeleji, O, Brown, BD, Ragoonanan, D, Waseemuddin, M, Shoberu, B, Kawedia, J, Khazal, SJ, Connors, JS, Petropoulos, D, Tewari, P, Bonfim, C, Driscoll, TA, DePriest, BP, Mahadeo, KM. Pre-transplant immunosuppression in pediatric patients undergoing haploidentical stem cell transplant for sickle cell disease is associated with positive outcomes. Bone marrow transplantation 61: 241-244, 2026.
Patient Reviews
CV information above last modified July 22, 2026